Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 4 51-4, 2005, Pages

  Akiho, Hirotada ^a,b   Lovato, Paola ^a   Deng, Yikang ^a   Ceponis, Peter J M ^a   Blennerhassett, Patricia ^a   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Interleukin 13; Interleukin 4; Intestinal smooth muscle cell

Indexed keywords

CARBACHOL; INTERLEUKIN 13; INTERLEUKIN 4; LEFLUNOMIDE; STAT6 PROTEIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CROHN DISEASE; DNA BINDING; DOSE RESPONSE; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; INTESTINE CONTRACTION; INTESTINE MOTILITY; INTESTINE MUSCLE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD3; CARBACHOL; CASE-CONTROL STUDIES; CELLS, CULTURED; CROHN DISEASE; DNA; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; INTESTINES; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; STAT6 TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION; TRANS-ACTIVATORS;

EID: 15244359470     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00273.2004     Document Type: Article

References (57)

1. Aithal GP, Day CP, Leathart J, Daly AK, and Hudson M. Association of single nucleotide polymorphisms in the interleukine-4 gene and interleukine-4 receptor gene with Crohn's disease in a British population. Genes and Immunity 2: 44-47, 2001.
2. Akiho H, Blennerhassett P, and Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 282: G226-G232, 2002.
3. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, and Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 32: 1107-1177, 1997.
4. Bickston SJ and Cominelli F. Treatment of Crohn's disease at the turn of the century. N Engl J Med 339: 401-402, 1998.
5. Black PN, Young PG, and Skinner SJ. Response of airway smooth muscle cells to TGF-β1: effects on growth and synthesis of glycosaminoglycans. Am J Physiol Lung Cell Mol Physiol 271: L910-L917, 1996.
6. Blennerhassett MG, Bovell FM, Lourenssen S, and McHugh KM. Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell. Dig Dis Sci 44: 1265-1272, 1999.
7. Blennerhassett MG, Vignjevic P, Vermillion DL, and Collins SM. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. Am J Physiol Gastrointest Liver Physiol 262: G1041-G1046, 1992.
8. Blennerhassett MG, Vignjevic P, Vermillion DL, Ernst PB, and Collins SM. Intestinal inflammation induces T-lymphocyte dependent hyperplasia of jejunal smooth muscle (Abstract). Gastroenterology 98: A328, 1990.
9. Blennerhassett P and Collins SM. TH-1 and TH-2 cytokines differ in their effects on smooth muscle contractility in the rodent gut (Abstract). Gastroenterology 110: A867, 1996.
10. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, and MacDonald TT. Interleukin-2 and interferon-gamma secreting T cells in normal and diseased human intestinal mucosa. Immunology 78: 127-131, 1993.
11. Collins SM. Calcium utilization by dispersed canine gastric smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 251: G181-G188, 1986.
12. Collins SM. The immunomodulation of enteric neuromuscular function; implications for motility and inflammatory disorders. Gastroenterology 111: 1683-1689, 1996.
13. Desreumaux P, Brandt E, Gambiez L, Emilie D, Geboes K, Klein O, Ectors N, Cortot A, Capron M, and Colombel JF. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113: 118-126, 1997.
14. De Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102: 165-169, 1998.
15. D'Haens G, Colpaert FC, Peeters F, Baert F, Penninckx F, and Rutgeerts P. The presence and severity of neural inflammation predict severe post-operative recurrence of Crohn's disease (Abstract). Gastroenterology 114: A963, 1998.
16. D'Haens G and Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflamm Bowel Dis 5: 295-303, 1999.
17. Elovic AE, Ohyama H, Sauty A, McBride J, Tsuji T, Nagai M, Weller PF, and Wong DT. IL-4-dependent regulation of TGF-α and TGF-β1 expression in human eosinophils. J Immunol 160: 6121-6127, 1998.
18. Fell JM, Walker-Smith JA, Spencer J, and MacDonald TT. The distribution of dividing T cells throughout the intestinal wall in inflammatory bowel disease (IBD). Clin Exp Immunol 104: 280-285, 1996.
19. Finkelman FD, Wynn TA, Donaldson DD, and Urban JF. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr Opin Immunol 11: 420-426, 1999.
20. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205, 1998.
21. Fryer AD, Adamko DJ, Yost BL, and Jacoby DB. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung. Life Sci 64: 449-455, 1999.
22. Geboes K, Rutgeerts P, Ectors N, Mebis J, Penninckx F, Vantrappen G, and Desmet VJ. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 103: 439-447, 1992.
23. Goldhill J, Morris SC, Maliszewski C, Urban JF, Funk CD, Finkelman FD, and Shea-Donohue T. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. Am J Physiol Gastrointest Liver Physiol 272: G1135-G1140, 1997.
24. Gotze H and Ptok A. Orocaecal transit time in patients with Crohn disease. Eur J Pediatr 152: 193-196, 1993.
25. Graham MF, Bryson GR, and Diegelmann RF. Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 99: 447-453, 1990.
26. Graham MF, Diegelmann MF, Elson CO, Bitar KN, and Ehrlich HP. Isolation and culture of human intestinal smooth muscle cells. Proc Soc Exp Biol Med 176: 503-507, 1984.
27. Graham MF. Pathogenesis of intestinal strictures in Crohn's disease - an update. Inflammatory Bowel Diseases 1: 220-227, 1995.
28. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, and Wilson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93: 497-501, 1996.
29. Hyams JS, Fitzgerald JE, Wyzga N, Treem WR, Justinich CJ, and Kreutzer DL. Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Dig Dis Sci 39: 1893-1899, 1994.
30. Khan WI, Vallance BA, Blennerhassett PA, Deng Y, Verdu EF, Matthaei KI, and Collins SM. Critical role for signal transduction and activation of transcription factor 6 in mediating intestinal muscle hypercontractility and worm expulsion in Trichinella spiralis-infected mice. Infect Immun 69: 838-844, 2001.
31. Manna SK, Mukhopadhyay A, and Aggarwal BB. Leflunomide suppresses TNF-induced cellular responses: effects on NF-κB, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis. J Immunol 165: 5962-5969, 2000.
32. Mattar T, Kochhar K, Bartlett R, Bremer EG, and Finnegan A. Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett 334: 161-164, 1993.
33. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, and Pallone F. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112: 1169-1178, 1997.
34. Nelms K, Keegan AD, Zamorano J, Ryan JJ, and Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17: 701-738, 1999.
35. Ohmori Y, Smith MF, and Hamilton TA. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157: 2058-2065, 1996.
36. Pallone F and Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 43: 735-736; 1998.
37. Podolsky DK. Inflammatory bowel dsiease. N Engl J Med 325: 928-937, 1991.
38. Postlethwaite AE, Holness MA, Katai H, and Raghow R. Human fibroblasts synthesise elevated levels of extracellular matrix proteins in response to interleukine-4. J Clin Invest 90: 1479-1485, 1992.
39. Radojevic N, McKay DM, Merger M, Vallance BA, Collins SM, and Croitoru K. Characterization of enteric functional changes evoked by in vivo anti- CD3 T cell activation. Am J Physiol Regul Integr Comp Physiol 276: R715-R723, 1999.
40. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106: 533-539, 1994.
41. Schindler C and Darnell JE. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64: 621-651, 1995.
42. Sempowski GD, Derdak S, and Phipps RP. Interleukine-4 and interferon-γ discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 167: 290-296, 1996.
43. Shi Z, Wakil AE, and Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94: 10663-10668, 1997.
44. Siemasko K, Chong AS, Jack HM, Gong H, Williams JW, and Finnegan A. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol 160: 1581-1588, 1998.
45. Smerz-Bertling C and Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140 kDa subunit of the interleukin 4 receptor. J Biol Chem 270: 966-970, 1995.
46. Stallmach A, Schuppan D, Riese HH, Matthes H, and Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 102: 1920-1929, 1992.
47. Straub RH, Antoniou E, Zeuner M, Gross V, Scholmerich J, and Andus T. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. J Neuroimmunol 80: 149-157, 1997.
48. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJ, Kluin PM, Meinders AE, Yanni G, Panayi GS, and Breedveld FC. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 38: 1457-1465, 1995.
49. Targan SR and Murphy LK. Clarifying the causes of Crohn's. Nat Med 1: 1241-1243, 1995.
50. Vallance BA, Croitoru K, and Collins SM. T lymphocyte-dependent and -independent intestinal smooth muscle dysfunction in the T. spiralis-infected mouse. Am J Physiol Gastrointest Liver Physiol 275: G1157-G1165, 1998.
51. Vallance BA, Hogaboam CM, Addison CL, Gauldie J, and Collins SM. Interleukine-4 gene transfer to the intestine causes inflammation and muscle dysfunction in the mouse (Abstract). Gastroenterology 110: A1034, 1996.
52. Vermillion DL, Ernst PB, and Collins SM. T-lymphocyte modulation of intestinal muscle function in the Trichinella-infected rat. Gastroenterology 101: 31-38, 1991.
53. Vermillion DL, Huizinga JD, Riddell RH, and Collins SM. Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology 104: 1692-1699, 1993.
54. Welham MJ, Learmonth L, Bone H, and Schrader JW. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 270: 12286-12296, 1995.
55. Xu X, Williams JM, Bremer EG, Finnegan A, and Chong AS. Inhibition of tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem 270: 12398-12403, 1995.
56. Yu CR, Kirken RA, Malabarba MG, Yound HA, and Ortaldo JR. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 161: 218-227, 1998.
57. Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie AN, Miossec P, Banchereau J, and Zurawski G. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270: 13869-13878, 1995.